ロード中...
Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
Several studies have linked circulating cell-free mitochondrial DNA (ccf-mtDNA) to human disease. In particular, reduced ccf-mtDNA levels in the cerebrospinal fluid (CSF) of both Alzheimer’s and Parkinson’s disease (PD) patients have raised the hypothesis that ccf-mtDNA could be used as a biomarker...
保存先:
| 出版年: | Mol Neurodegener |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7029508/ https://ncbi.nlm.nih.gov/pubmed/32070373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00362-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|